RIPPLY1 is a transcriptional repressor essential for embryonic somitogenesis and segmentation. Primary function: RIPPLY1 acts as a Groucho/TLE-associated corepressor that converts T-box transcription factors from activators to repressors 1. During somite development, RIPPLY1 represses segmentation genes like mesp-b in the presomitic mesoderm, terminating the segmentation program and maintaining rostrocaudal polarity in newly formed somites 2. Mechanism: RIPPLY1 associates directly with T-box proteins (including Tbx24 and TBX19) through a Groucho-interacting motif, recruiting the corepressor complex to suppress transcriptional activation 1, 3. Disease relevance: RIPPLY1 variants are implicated in multiple developmental disorders. Hemizygous RIPPLY1 deletions were identified in laterality defect cases 4, and protein-truncating variants were found in congenital scoliosis patients 5. X-linked RIPPLY1 mutations have been associated with intellectual disability and ataxia 6. Clinical significance: In hepatocellular carcinoma with CTNNB1 mutations, RIPPLY1 suppresses cancer stem cell properties by targeting TBX19 degradation, with higher RIPPLY1 correlating with better patient prognosis 3. RIPPLY1 polymorphisms are also associated with alcohol-induced chrX pancreatitis risk 7.